- Home
- QLEP vs INFU Comparison
QLEP vs INFU Comparison
Compare QLEP & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QLEP | INFU |
|---|---|---|
| Founded | 2025 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.6M | 277.6M |
| IPO Year | 2026 | 2005 |
Fundamental Metrics
Financial Performance| Metric | QLEP | INFU |
|---|---|---|
| Price | $10.08 | $13.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.83 |
| AVG Volume (30 Days) | 45.6K | ★ 118.6K |
| Earning Date | N/A | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | N/A | $1.20 |
| Revenue Next Year | N/A | $6.16 |
| P/E Ratio | ★ N/A | $65.75 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $9.93 | $7.29 |
| 52 Week High | $10.10 | $14.64 |
Technical Indicators
Market Signals| Indicator | QLEP | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 48.96 |
| Support Level | N/A | $13.25 |
| Resistance Level | $10.10 | $13.85 |
| Average True Range (ATR) | 0.01 | 0.62 |
| MACD | -0.00 | -0.13 |
| Stochastic Oscillator | 60.00 | 47.94 |
Price Performance
Historical ComparisonAbout QLEP Quantum Leap Acquisition Corp Class A Ordinary Shares
Quantum Leap Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.